Future directions in the treatment of osteosarcoma
MW Bishop, KA Janeway, R Gorlick - Current opinion in pediatrics, 2016 - journals.lww.com
Future directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Future
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …
Therapy for osteosarcoma: where do we go from here?
AJ Chou, DS Geller, R Gorlick - Pediatric Drugs, 2008 - Springer
Osteosarcoma is the most common malignant primary bone tumor in children and
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
Origin and therapies of osteosarcoma
B Moukengue, M Lallier, L Marchandet, M Baud'huin… - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcoma is the most common malignant bone tumor in children, with
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …
Current status and perspectives regarding the treatment of osteosarcoma: chemotherapy
A Sakamoto, Y Iwamoto - Reviews on recent clinical trials, 2008 - ingentaconnect.com
Osteosarcoma is the most common primary bone tumor in childhood and adolescence. The
use of combination chemotherapy and surgery enables long-term survival in approximately …
use of combination chemotherapy and surgery enables long-term survival in approximately …
Novel therapeutic agents for osteosarcoma
K O'Day, R Gorlick - Expert review of anticancer therapy, 2009 - Taylor & Francis
Osteosarcoma is the most common malignant primary bone tumor in childhood. Despite
multiagent chemotherapy and aggressive surgical resection, 30% of patients with localized …
multiagent chemotherapy and aggressive surgical resection, 30% of patients with localized …
Current therapeutic strategies and novel approaches in osteosarcoma
K Ando, MF Heymann, V Stresing, K Mori, F Rédini… - Cancers, 2013 - mdpi.com
Osteosarcoma is the most frequent malignant primary bone tumor and a main cause of
cancer-related death in children and adolescents. Although long-term survival in localized …
cancer-related death in children and adolescents. Although long-term survival in localized …
Osteosarcoma: current treatment and a collaborative pathway to success
MS Isakoff, SS Bielack, P Meltzer… - Journal of clinical …, 2015 - ascopubs.org
Osteosarcoma is the bone tumor that most commonly affects children, adolescents, and
young adults. Before 1970, treatment primarily included surgical resection. However, the …
young adults. Before 1970, treatment primarily included surgical resection. However, the …
The current and future therapies for human osteosarcoma
JD Lamplot, S Denduluri, J Qin, R Li… - Current cancer …, 2013 - ingentaconnect.com
Osteosarcoma (OS) is the most common non-hematologic malignant tumor of bone in adults
and children. As sarcomas are more common in adolescents and young adults than most …
and children. As sarcomas are more common in adolescents and young adults than most …
Osteosarcoma
HC Beird, SS Bielack, AM Flanagan, J Gill… - Nature reviews Disease …, 2022 - nature.com
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
Emerging drugs for high-grade osteosarcoma
CM Hattinger, M Pasello, S Ferrari, P Picci… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Osteosarcoma (OS) is the most common primary malignant bone
tumour in children and adolescents. This review focuses on the most promising therapeutic …
tumour in children and adolescents. This review focuses on the most promising therapeutic …